SCHEMBL21609129

SCHEMBL21609129

COc1ccccc1S(=O)(=O)Nc1noc2ccccc12

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 11/20 0.74
KAT7 O95251 10/20 0.60
KAT6B Q8WYB5 2/20 0.60
BRD4 O60885 2/20 0.58
KMT2A Q03164 1/20 0.52
EDNRA P25101 1/20 0.50
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
PTPN5 P54829 1/20 0.49
CCNT1 O60563 1/20 0.48
CDK9 P50750 1/20 0.48
KAT5 Q92993 1/20 0.47
KAT8 Q9H7Z6 1/20 0.47
HIF1A Q16665 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29652570 1.00 KAT6A (0.74) KAT6AKAT7KAT6BBRD4KMT2A
SCHEMBL21609246 0.87 KAT6A (0.64) KAT6AKAT7KAT6BKMT2AKAT5
SCHEMBL21609114 0.87 KAT6A (0.78) KAT6AKAT7KAT6BBRD4KMT2A
SCHEMBL29652535 0.87 KAT6A (0.78) KAT6AKAT7KAT6BBRD4KMT2A
SCHEMBL21609026 0.87 KAT6A (0.67) KAT6AKAT7KAT6BBRD4KMT2A
SCHEMBL21641922 0.87 KAT6A (0.78) KAT6AKAT7KAT6BBRD4KMT2A
SCHEMBL29652452 0.87 KAT6A (0.78) KAT6AKAT7KAT6BBRD4KMT2A
SCHEMBL21609171 0.86 KAT6A (0.76) KAT6AKAT7KAT6BBRD4KAT5
SCHEMBL21609149 0.86 KAT6A (0.66) KAT6AKAT7KAT6BBRD4KMT2A
SCHEMBL21609131 0.86 KAT6A (0.62) KAT6AKAT7KAT6BBRD4EDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 KAT6A 877/4885KAT7 490/4885KAT6B 1005/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 KAT6A 878/4885KAT7 490/4885KAT6B 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.